Skip to main content
. 2023 Sep 21;17:1603. doi: 10.3332/ecancer.2023.1603

Table 2. Proportion of HNC to all-site cancer by regions of India along with other countries by gender.

Region/country (year) Male Female
All-site cancer HNC All-site cancer HNC
Number % Number %
Central (2012–2016) 11,897 4,061 34.1 12,160 1,284 10.6
East (2012–2015) 10,173 2,086 20.5 9,130 634 6.9
North (2012–2019) 42,803 10,325 24.1 41,160 2,301 5.6
Northeast (2012–2016) 36,800 10,216 27.8 30,540 3,195 10.5
South (2012–2018) 58,444 12,290 21.0 66,262 4,516 6.8
West (2012–2018) 57,930 17,068 29.5 57,995 4,865 8.4
India (2012–2019) 218,047 56,046 25.7 217,247 16,795 7.7
SSDM, Nepal (2019) 579 121 20.9 609 40 6.6
Colombo, Sri Lanka (2019) 1,811 275 15.2 2,304 68 3.0
USA (2008–2012) 3,899,202 169,585 4.3 3,656,287 59,788 1.6
UK (2008–2012) 877,231 32,273 3.7 828,286 13,530 1.6
Uganda, Kyadondo country (Africa)
(2008–2012)
3,587 186 5.2 4,414 95 2.2
Curitiba, Brazil
(2008–2011)
8,624 640 7.4 9,398 154 1.6
Australia
(2008–2012)
338,865 13,532 4.0 258,931 4,679 1.8